The therapeutic response to D-penicillamine in rheumatoid arthritis: Influence of glutathione S-transferase polymorphisms

Rheumatology

Volumn 38, Issue 1, 1999, Pages 43-47

  Layton, M A ^a   Jones, P W ^b   Alldersea, J E ^b   Strange, R C ^b   Fryer, A A ^b   Dawes, P T ^a   Mattey, D L ^a  

^a Staffordshire Rheumatology Centre   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

Author keywords

D pencillamine; Glutathione S transferase; Polymorphism; Rheumatoid arthritis; Therapeutic response

Indexed keywords

GLUTATHIONE TRANSFERASE; PENICILLAMINE;

ADULT; AGED; ARTICLE; DISEASE ACTIVITY; DNA POLYMORPHISM; DRUG EFFICACY; ENZYME POLYMORPHISM; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACOGENETICS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HAPLOTYPES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PENICILLAMINE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0032708418     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.1.43     Document Type: Article

References (30)

1. Gough A, Faint J, Salmon M et al. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum 1994;37:1166-70.
2. Symmons DPM, Ollier WER, Brennan P, Silman AJ. Should patients with recent onset rheumatoid arthritis be offered genetic screening? Ann Rheum Dis 1996;55:407-10.
3. Ten Wolde S, Dijkmans BAC, Van Rood JJ et al. Human leucocyte antigen phenotypes and gold induced remission in patients with rheumatoid arthritis. Br J Rheumatol 1995;34:343-6.
4. Panayi GS, Wooley P, Batchelor JR. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations and toxic reactions to drugs. Br Med J 1978;2:1326-8.
5. Beyeler C, Frey BM, Bird HA. Urinary 6 beta-hydroxycortisol excretion in rheumatoid arthritis. Br J Rheumatol 1997;36:54-8.
6. Strange RC, Fryer AA. The glutathione S-transferases: influence of polymorphism on susceptibility to non familial cancers. In: Boffetta P, Caporaso N, Cuzick J, Lang M, Vineis P, eds. Metabolic polymorphisms and cancer. Lyon: IARC Scientific Publications, in press.
7. Ketterer B, Taylor J, Meyer D et al. Some functions of glutathione transferases. In: Tew KD, Pickett CB, Mantle TJ, Mannerick B, Hayes JD, eds. Structure and function of glutathione transferases. Boca Raton, FL: CRC Press, 1993:15-27.
8. Ranganathan S, Tew KD. Immunohistochemical localisation of glutathione transferases α, μ, and π in normal tissue and carcinomas from human colon. Carcinogenesis 1991;12:2382.
9. Hassell AB, Plant MJ, Davis M et al. Influence of glutathione S-transferase polymorphisms on the incidence and severity of rheumatoid arthritis. Br J Rheumatol 1995;34:18.
10. Benov LC, Ribarov SR, Monovich OH. Study of activated oxygen production by some thiols using chemiluminescence. Gen Physiol Biophys 1992;11:195-202.
11. Pronai L, Ichikawa Y, Ichimori K et al. Hydroxyl radical-scavenging activity of slow acting antirheumatic drugs. J Clin Biochem Nutr 1990;9:17-23.
12. Munthe E, Guldal G, Jellum E. Increased intracellular glutathione during penicillamine treatment for rheumatoid arthritis. Lancet 1979;ii:1126-7.
13. Jones PW, Ziade MF, Davis MJ, Dawes PT. An index of disease activity in rheumatoid arthritis. Stat Med 1993;12:1171-8.
14. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
15. Borg AA, Fowler PD, Shadforth MF, Dawes PT. Use of the Stoke Index to differentiate between disease-modifying agents and non-steroidal anti-inflammatory drugs in rheumatoid arthritis. Clin Exp Rheumatol 1993;11:469-72.
16. Mattey DL, Hassell AB, Plant MJ et al. Association of radiological outcome in RA with polymorphisms in the glutathione S-transferase supergene family. Arthritis Rheum 1997;40:S330.
17. Heagerty AHM, Fitzgerald D, Smith A et al. Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous malignancy. Lancet 1994;343:266-8.
18. Heagerty AHM, Smith A, English J et al. Susceptibility to multiple cutaneous basal cell carcinomas: Significant interactions between glutathione S-transferase GSTM1 genotypes, skin type and male gender. Br J Cancer 1996;73:44-8.
19. Inskip A, Elexperu-Camiruaga J, Buxton N et al. Identification of polymorphism at the glutathione S-transferase, GSTM3 locus: Evidence for linkage with GSTM1*A. Biochem J 1995;312:713-6.
20. Harries LW, Stubbins MJ, Forman D, Howard GCW, Wolf CR. Identification of genetic polymorphism at the GSTP1 locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997;18:641-4.
21. Elexpuru-Camiruaga J, Buxton N, Kandula V et al. Susceptibility to astrocytoma and meningioma: influence of allelism of glutathione S-transferase, GSTT1 and GSTM1 and cytochrome P450, CYP2D6 loci. Cancer Res 1995;55:4237-9.
22. Altman D. Practical statistics for medical research. London: Chapman and Hall, 1991:352-4.
23. Vaury C, Laine R, Noguiez P, de Coppet P et al. Human glutathione S-transferase M1 null genotype is associated with a high inducibility of cytochrome P450 1A1 gene transcription. Cancer Res 1995;55:5520-3.
24. Yengi L, Inskip A, Gilford J et al. Polymorphism at the glutathione S-transferase GSTM3 locus: Interactions with cytochrome P450 and the glutathione S-transferase genotypes as risk factors for multiple basal cell carcinoma. Cancer Res 1996;56:1974-7.
25. Antilla S, Luostarinen L, Hirvonen A et al. Pulmonary expression of glutathione S-transferase M3 in lung cancer patients: association with GSTM1 polymorphism, smoking and asbestos exposure. Cancer Res 1995;55:3305-9.
26. Flanagan JR. Autologous stimulation of YY1 transcription factor expression: role of an insulin like growth factor. Cell Growth Differ 1995;6:185-90.
27. Ledson MJ, Bucknall RC, Edwards SW. Inhibition of neutrophil oxidant secretion by D penicillamine: scavenging of H2O2 and HOC1. Ann Rheum Dis 1992;51:321-5.
28. Maurice MM, Nakamura H, van der Voort EA et al. Evidence for the role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis. J Immunol 1997;158:1458-65.
29. Tew KD. Glutathione associated enzymes in anticancer drug resistance. Cancer Res 1994;54:4313-20.
30. Hamilton TC, Yao KS, Beesley JS et al. The relationship and regulation of glutathione in cancer cells resistant to chemotherapy. In: Vermeulen NP, Mulder GJ, Nieuwenhuyse H et al., eds. Glutathione S-transferases - structure, function and clinical implications, TJ Press (Padstow) Ltd; Taylor & Francis, UK, 1996:173-85.